Key facts
- It has raised $27.0M; the latest was Early Stage VC ($19.5M) in Sep 2025.
- Notable investors include Google for Startups, Base10 Partners, Canary (Brazil), Kaszek, Endeavor Group Holdings — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Arvo
- ·The full record, as it builds
Funding rounds
No funding rounds for Arvo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arvo
Developer of an auditing software designed to provide tools to automate claims auditing. The company's software offers artificial intelligence and machine learning models to make account analyses, medical knowledge and audit experience, as well as proprietary technology, enabling the healthcare sector to reduce fraud, abuse, and waste in the system, making health more accessible to all.
- Sector
- Healthcare
- HQ
- Rio de Janiero, Brazil
- Founded
- 2022
- Employees
- 69
- Website
- arvo.com.br/
- Ownership
- Privately Held (backing)
Arvo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arvo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arvo in its N-PORT filings yet. We sweep new filings monthly.